Correlation Between Spyre Therapeutics and Buckeye

Can any of the company-specific risk be diversified away by investing in both Spyre Therapeutics and Buckeye at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spyre Therapeutics and Buckeye into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Spyre Therapeutics and Buckeye Partners 675, you can compare the effects of market volatilities on Spyre Therapeutics and Buckeye and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spyre Therapeutics with a short position of Buckeye. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spyre Therapeutics and Buckeye.

Diversification Opportunities for Spyre Therapeutics and Buckeye

-0.16

Correlation Coefficient

Spyre Therapeutics  Buckeye

Good diversification

The 3 months correlation between Spyre and Buckeye is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and Buckeye Partners 675 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Buckeye Partners 675 and Spyre Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spyre Therapeutics are associated (or correlated) with Buckeye. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Buckeye Partners 675 has no effect on the direction of Spyre Therapeutics i.e., Spyre Therapeutics and Buckeye go up and down completely randomly.

Pair Corralation between Spyre Therapeutics and Buckeye

Given the investment horizon of 90 days Spyre Therapeutics is expected to under-perform the Buckeye. But the stock apears to be less risky and, when comparing its historical volatility, Spyre Therapeutics is 1.3 times less risky than Buckeye. The stock trades about -0.05 of its potential returns per unit of risk. The Buckeye Partners 675 is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest  10,221  in Buckeye Partners 675 on September 17, 2024 and sell it today you would lose (341.00) from holding Buckeye Partners 675 or give up 3.34% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	26.56%
Values	Daily Returns

Spyre Therapeutics  vs.  Buckeye Partners 675

Spyre Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Spyre Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest inconsistent performance, the Stock's basic indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Buckeye Partners 675

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Buckeye Partners 675 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Buckeye is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Spyre Therapeutics and Buckeye

The main advantage of trading using opposite Spyre Therapeutics and Buckeye positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spyre Therapeutics position performs unexpectedly, Buckeye can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Buckeye will offset losses from the drop in Buckeye's long position.

The idea behind Spyre Therapeutics and Buckeye Partners 675 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.